Charles Schwab’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Charles Schwab’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,589	Closed	-$27.2K	–	3553
2024 Q3	$27.2K	Hold	11,589	–	–	﹤0.01%	3470
2024 Q2	$10.2K	Hold	11,589	–	–	﹤0.01%	3614
2024 Q1	$47.4K	Hold	11,589	–	–	﹤0.01%	3375
2023 Q4	$67.8K	Hold	11,589	–	–	﹤0.01%	3374
2023 Q3	$59.7K	Hold	11,589	–	–	﹤0.01%	3393
2023 Q2	$55.7K	Sell	11,589 -8,900	-43%	-$30.8K	﹤0.01%	3410
2023 Q1	$35.7K	Buy	+20,489	New	+$33.4K	﹤0.01%	3415

Charles Schwab's AUGX Position: Q4 2024 in Review

Charles Schwab sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 11,589 shares — an estimated $27.2K sold.

Charles Schwab first reported a position in AUGX in Q1 2023 and held it in 7 quarters. The position peaked at $67.8K in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Charles Schwab reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Charles Schwab sold 11,589 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $27.2K.
Charles Schwab first reported a position in Augmedix, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Charles Schwab's Augmedix, Inc. Common Stock position peaked at $67.8K in Q4 2023.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.